Anthony Germinaro Joins PetVivo Holdings, Inc. as Field Veterinary Business Development Manager
PetVivo Holdings, Inc. (OTCB: PETV & PETVW), a growing biomedical device company focused on creating innovative medical devices and therapies for companion animals and animal athletes, is excited to announce that Anthony Germinaro has been appointed as the new Field Veterinary Business Development Manager for the Southwest Region of the United States.
Leadership Insights
John Lai, the Chief Executive Officer of PetVivo Holdings, Inc., shared his excitement about Germinaro joining the sales and distribution team. “Bringing Anthony on board significantly strengthens PetVivo’s commercialization efforts,” said Lai. “His extensive experience in veterinary clinics is crucial for raising awareness of our groundbreaking product, Spryng with OsteoCushion technology, among veterinarians in the Southwest Region.”
Meet Anthony Germinaro
Anthony Germinaro comes with over 14 years of experience in the animal health sector, having built considerable expertise in veterinary clinics and in the sales of animal health products. His career includes roles such as lead ultrasound technician and practice manager, where he gained valuable experience in sales and clinic management at respected organizations like Dr. Fossum’s Pet Care, Anivive Life Sciences, Black Mountain Veterinary Cardiology, Banfield Pet Hospital, and VetMed.
Anthony's Aspirations
Expressing his enthusiasm, Anthony Germinaro stated, “Joining PetVivo as a Field Veterinary Business Development Manager is an amazing opportunity for me to pursue my passion, leverage my industry expertise, and improve the quality of life for horses and companion animals. I am excited to be part of a company that provides technology proven to enhance medical outcomes for animals facing lameness and joint-related issues, such as osteoarthritis.”
About PetVivo Holdings
PetVivo Holdings, Inc. (OTCQB: PETV, PETVW) is dedicated to the manufacturing, commercialization, and licensing of advanced medical devices and therapeutics for companion animals. The company aims to efficiently develop human therapies while speeding up the market entry of veterinary medical devices, which allows for quicker revenue generation compared to more heavily regulated human pharmaceuticals and biologics.
Innovative Products
PetVivo has developed a robust product pipeline targeting both animal and human medical treatments. With a portfolio of 21 patents covering its biomaterials, products, and methods of use, the company has introduced its flagship product, Spryng with OsteoCushion Technology. This veterinarian-administered, intra-articular injectable product is specifically designed to manage lameness and related joint conditions, including osteoarthritis, in cats, dogs, and horses.
Company Disclosure Information
PetVivo utilizes its Investor Relations website to disclose material nonpublic information and comply with Regulation FD. Investors are encouraged to frequently visit the Investor Relations site and stay updated with the company’s press releases, SEC filings, public conference calls, presentations, and webcasts.
Contact Information
Company Contact:
John Lai, CEO
PetVivo Holdings, Inc.
Email: info1@petvivo.com
Tel: (952) 405-6216
Investor Contact:
Ronald Both or Grant Stude
CMA Investor Relations
Tel: (949) 432-7566
Email: investor@petvivo.com
Frequently Asked Questions
1. Who is Anthony Germinaro?
Anthony Germinaro is the newly appointed Field Veterinary Business Development Manager for PetVivo Holdings, bringing over 14 years of experience in the animal health industry.
2. What role will Germinaro have at PetVivo?
He will focus on enhancing the company’s commercialization efforts in the Southwest Region of the United States, raising awareness for innovative products like Spryng with OsteoCushion technology.
3. What is Spryng with OsteoCushion Technology?
Spryng is an intra-articular injectable product designed for veterinarians to treat lameness and joint-related issues, including osteoarthritis, in companion animals.
4. What is the mission of PetVivo Holdings?
PetVivo focuses on developing and commercializing veterinary medical devices and therapeutics to improve the health and well-being of companion animals.
5. How can I contact PetVivo Holdings?
You can contact PetVivo Holdings through their CEO, John Lai, at the email info1@petvivo.com or call (952) 405-6216 for inquiries.
